|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Damber JE and Aus G: Prostate cancer.
Lancet. 371:1710–1721. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu S, Xie F, Wang H, Liu Z, Liu X, Sun L
and Niu Z: Ubenimex inhibits cell proliferation, migration and
invasion in renal cell carcinoma: The effect is
autophagy-associated. Oncol Rep. 33:1372–1380. 2015.PubMed/NCBI
|
|
4
|
Ikeda N, Nakajima Y, Tokuhara T, Hattori
N, Sho M, Kanehiro H and Miyake M: Clinical significance of
aminopeptidase N/CD13 expression in human pancreatic carcinoma.
Clin Cancer Res. 9:1503–1508. 2003.PubMed/NCBI
|
|
5
|
Tokuhara T, Hattori N, Ishida H, Hirai T,
Higashiyama M, Kodama K and Miyake M: Clinical significance of
aminopeptidase N in non-small cell lung cancer. Clin Cancer Res.
12:3971–3978. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bogenrieder T, Finstad CL, Freeman RH,
Papandreou CN, Scher HI, Albino AP, Reuter VE and Nanus DM:
Expression and localization of aminopeptidase A, aminopeptidase N,
and dipeptidyl peptidase IV in benign and malignant human prostate
tissue. Prostate. 33:225–232. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu AY, Roudier MP and True LD:
Heterogeneity in primary and metastatic prostate cancer as defined
by cell surface CD profile. Am J Pathol1. 165:1543–1556. 2004.
View Article : Google Scholar
|
|
8
|
Dall'Era MA, True LD, Siegel AF, Porter
MP, Sherertz TM and Liu AY: Differential expression of CD10 in
prostate cancer and its clinical implication. BMC Urol. 7:32007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ishii K, Usui S, Sugimura Y, Yoshida S,
Hioki T, Tatematsu M, Yamamoto H and Hirano K: Aminopeptidase N
regulated by zinc in human prostate participates in tumor cell
invasion. Int J Cancer. 92:49–54. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fontijn D, Duyndam MC, van Berkel MP,
Yuana Y, Shapiro LH, Pinedo HM, Broxterman HJ and Boven E:
CD13/Aminopeptidase N overexpression by basic fibroblast growth
factor mediates enhanced invasiveness of 1F6 human melanoma cells.
Br J Cancer. 94:1627–1636. 2006.PubMed/NCBI
|
|
11
|
Mina-Osorio P: The moonlighting enzyme
CD13: Old and new functions to target. Trends Mol Med. 14:361–371.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Horita H, Frankel AE and Thorburn A: Acute
myeloid leukemia-targeted toxin activates both apoptotic and
necroptotic death mechanisms. PLoS One. 3:e39092008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mujtaba SF, Dwivedi A, Yadav N, Ch R,
Kushwaha HN, Mudiam MK, Singh G and Ray RS: Superoxide mediated
photo-modification and DNA damage induced apoptosis by Benz(a)
anthracene via mitochondrial mediated pathway. J Photochem
Photobiol B. 142:92–102. 2015. View Article : Google Scholar
|
|
14
|
Sørensen KD, Abildgaard MO, Haldrup C,
Ulhøi BP, Kristensen H, Strand S, Parker C, Høyer S, Borre M and
Ørntoft TF: Prognostic significance of aberrantly silenced ANPEP
expression in prostate cancer. Br J Cancer. 108:420–428. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ishii K, Usui S, Sugimura Y, Yamamoto H,
Yoshikawa K and Hirano K: Inhibition of aminopeptidase N (AP-N) and
urokinase-type plasminogen activator (uPA) by zinc suppresses the
invasion activity in human urological cancer cells. Biol Pharm
Bull. 24:226–230. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hashida H, Takabayashi A, Kanai M, Adachi
M, Kondo K, Kohno N, Yamaoka Y and Miyake M: Aminopeptidase N is
involved in cell motility and angiogenesis: Its clinical
significance in human colon cancer. Gastroenterology. 122:376–386.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Murakami H, Yokoyama A, Kondo K, Nakanishi
S, Kohno N and Miyake M: Circulating aminopeptidase N/CD13 is an
independent prognostic factor in patients with non-small cell lung
cancer. Clin Cancer Res. 11:8674–8679. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wickström M, Larsson R, Nygren P, Gullbo J
and Aminopeptidase N: Aminopeptidase N (CD13) as a target for
cancer chemotherapy. Cancer Sci. 102:501–508. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ichinose Y, Genka K, Koike T, Kato H,
Watanabe Y, Mori T, Iioka S, Sakuma A and Ohta M; NK421 Lung Cancer
Surgery Group: Randomized double-blind placebo-controlled trial of
bestatin in patients with resected stage I squamous-cell lung
carcinoma. J Natl Cancer Inst. 95:605–610. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wakita A, Ohtake S, Takada S, Yagasaki F,
Komatsu H, Miyazaki Y, Kubo K, Kimura Y, Takeshita A, Adachi Y, et
al: Randomized comparison of fixed-schedule versus
response-oriented individualized induction therapy and use of
ubenimex during and after consolidation therapy for elderly
patients with acute myeloid leukemia: The JALSG GML200 Study. Int J
Hematol. 96:84–93. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tsukamoto H, Shibata K, Kajiyama H,
Terauchi M, Nawa A, Kikkawa F and Aminopeptidase N: Aminopeptidase
N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in
human cervical cancer. BMC Cancer. 8:742008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu JW, Li CG, Huang XE, Li Y and Huo JG:
Ubenimex capsule improves general performance and chemotherapy
related toxicity in advanced gastric cancer cases. Asian Pac J
Cancer Prev. 12:985–987. 2011.PubMed/NCBI
|
|
23
|
Yang ZJ, Chee CE, Huang S and Sinicrope F:
Autophagy modulation for cancer therapy. Cancer Biol Ther.
11:169–176. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eum KH and Lee M: Crosstalk between
autophagy and apoptosis in the regulation of paclitaxel-induced
cell death in v-Ha-ras- transformed fibroblasts. Mol Cell Biochem.
348:61–68. 2011. View Article : Google Scholar
|
